We offer a complete biomarker discovery and validation package from initial study design through to the development of companion diagnostic tests:

• Biomarker Discovery. The identification of e.g. prognostic, predictive or pharmacodynamic biomarkers can be carried out using genomic or proteomic technologies. These studies can utilize samples from a wide range of sources including preclinical and clinical studies:
  • Study Design
  • Sample Processing
  • Data Analysis
• Assay Design and Validation services are available in both RUO and CLIA labs
• Migration Studies
• Biomarker Validation
  • Analytical Validation
  • Clinical Validation
• Commercial Kit Manufacture
• Companion Diagnostic Development

In addition to the development of assays for the detection of novel biomarkers, we have access to a large number of in-house kits that can be tailored and validated to your particular biomarker requirements. A Project Manager will be assigned to act as the sole point of contact for all projects. This Project manager will be responsible for all aspects of the project lifecycle including organisation of sample shipments, scheduling, processing & return of data.

For further information on our service offering please email pharmaservices@gen-probe.com